Güleser GÖKTAŞ, Şevin GÜNEY, Gülnur TAKE KAPLANOĞLU, Sibel DİNÇER

Neuroprotective role of delta opioid receptors in hypoxic preconditioning

Background/aim: The purpose of the present study was to explore the neuroprotective role of delta opioid receptors (DOR) in the ratcortex in hypoxic preconditioning.Materials and methods: Rats were randomly divided into 8 groups: control (C), sham (S), hypoxic preconditioning (PC), severe hypoxia(SH), PC + SH, PC + SH + Saline (PS), PC + SH + DPDPE (DPDPE, selective DOR agonist), PC + SH + NT (NT, Naltrindole, selectiveDOR antagonist). Drugs were administered intracerebroventrically. Twenty four h after the end of 3 consecutive days of PC (10% O2,2 h/day), the rats were subjected to severe hypoxia (7% O2 for 3 h). Bcl-2 and cyt-c were measured by western blot, and caspase-3 wasobserved immunohistochemically.Results: Bcl-2 expressions in the PC group were higher than in control, SH, and PC + SH groups. Even though there were no significantdifferences between the groups in terms of cyt-c levels, caspase-3 immunoreactivity of cortical neurons and glial cells in the severehypoxia and NT groups were higher than in the control, sham, and hypoxic preconditioning groups. DPDPE administration diminishedcaspase-3 immunoreactivity compared with all of the severe hypoxia groups.Conclusions: These results suggest that cortical cells are resistant to apoptosis via increased expression of Bcl-2 and decreasedimmunoreactivity of caspase-3 in the cortex, and that DOR is involved in neuroprotection induced by hypoxic preconditioning via thecaspase-3 pathway in cortical neurons.

PDF

___

1. Kang X, Chao D, Gu Q, Ding G, Wang Y et al. Delta-Opioid receptors protect from anoxic disruption of Na+ homeostasis via Na+ channel regulation. Cellular and Molecular Life Sciences 2009; 66(21): 3505-3516. doi: 10.1007/s00018-009- 0136-x
2. Abbruscato TJ, Davis TP. Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. Journal of Pharmacology and Experimental Therapeutics 1999; 289(2): 668-675.
3. An P, Xue YX. Effects of preconditioning on tight junction and cell adhesion of cerebral endothelial cells. Brain Research 2009; 1272: 81-88. doi: 10.1016/j.brainres.2009.03.031
4. Bin-Jaliah I, Ammar HI, Mikhailidis DP, Dallak MA, AlHashem FH et al. Cardiac adaptive responses after hypoxia in an experimental model. Angiology 2010; 61(2): 145-156. doi: 10.1177/0003319709352486
5. Yang CC, Lin LC, Wu MS, Chien CT, Lai MK. Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alphadependent bcl-2 signaling. Transplantation 2009; 88(11): 1251- 1260. doi: 10.1097/TP.0b013e3181bb4a07
6. Zhang J, Qian H, Zhao P, Hong SS, Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke 2006; 37(4): 1094-1099. doi: 10.1161/01.STR.0000206444.29930.18
7. Zhang SX, Miller JJ, Gozal D, Wang Y. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. Journal of Applied Physiology 2004; 96(1): 392-397. doi: 10.1152/japplphysiol.00829.2003
8. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neuroscience Research 1995; 23(2): 121-145. doi: 10.1016/0168-0102(95)00933-K
9. Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 2005; 280(16): 16208-16218. doi: 10.1074/jbc. M408055200
10. Xia Y, Haddad GG. Major difference in the expression of delta- and mu-opioid receptors between turtle and rat brain. Journal of Comparative Neurology 2001; 436(2): 202-210. doi: 10.1002/cne.1061
11. Xia Y, Jiang C, Haddad GG. Oxidative and glycolytic pathways in rat [newborn and adult] and turtle brain: role during anoxia. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 1992; 262(Pt 2): R595-603. doi: 10.1152/ajpregu.1992.262.4.R595
12. Xia Y, Haddad GG. Ontogeny and distribution of opioid receptors in the rat brainstem. Brain Research 1991; 549(2): 181-193. doi: 10.1016/0006-8993(91)90457-7
13. Buresh Y, Koroleva VI, Korolev OS, Maresh V. Changes in the constant potential in brain structures in rats during focal ischemia and systemic hypoxia. Neuroscience and Behavioral Physiology 1999; 29(5): 569-579. doi: 10.1007/BF02461150
14. Dunn JF, Wadghiri YZ, Meyerand ME. Regional heterogeneity in the brain’s response to hypoxia measured using BOLD MR imaging. Magnetic Resonance in Medicine 1999; 41(4): 850- 854. doi: 10.1002/(SICI)1522-2594(199904)41:4<850::AIDMRM27>3.0.CO;2-L
15. Lin CS, Polsky K, Nadler JV, Crain BJ. Selective neocortical and thalamic cell death in the gerbil after transient ischemia. Neuroscience 1990; 35(2): 289-299. doi: 10.1016/0306- 4522(90)90083-G
16. Georges F, Normand E, Bloch B, Le Moine C. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Developmental Brain Research 1998; 109(2): 187-199. doi: 10.1016/S0165-3806(98)00082-0
17. Kornblum HI, Hurlbut DE, Leslie FM. Postnatal development of multiple opioid receptors in rat brain. Developmental Brain Research 1987; 465(1-2): 21-41. doi: 10.1016/0165- 3806(87)90226-4
18. Armstead WM. Nitric oxide contributes to opioid release from glia during hypoxia. Brain Research 1998; 813(2): 398-401. doi: 10.1016/S0006-8993(98)01022-1
19. Chen XQ, Du JZ. Hypoxia influences enkephalin release in rats. Neuroreport 2000; 11(7): 1555-1557
20. Yan S, Zhang C, Laferriere, Moss IR. Met-enkephalin-like immunoreactivity in microdialysates from nucleus tractus solitarii in piglets during normoxia and hypoxia. Brain Research 1995; 687(1-2): 217-220. doi: 10.1016/0006- 8993(95)00541-W
21. Borlongan CV, Hayashi T, Oeltgen PR, Su TP, Wang Y. Hibernation-like state induced by an opioid peptide protects against experimental stroke. BMC Biology 2009; 7: 31. doi: 10.1186/1741-7007-7-31
22. Borlongan CV, Wang Y, Su TP. Delta opioid peptide [D-Ala 2, D-Leu 5] enkephalin: linking hibernation and neuroprotection. Frontiers in Bioscience 2004; 9: 3392-3398.
23. Iwata M, Inoue S, Kawaguchi M, Nakamura M, Konishi N et al. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia. British Journal of Anaesthesia 2007; 99(4): 538-546. doi: 10.1093/bja/aem220
24. Kao TK, Ou YC, Liao SL, Chen WY, Wang CC et al. Opioids modulate post-ischemic progression in a rat model of stroke. Neurochemistry International 2008; 52(6): 1256-1265. doi: 10.1016/j.neuint.2008.01.007
25. Su DS, Wang ZH, Zheng YJ, Zhao YH, Wang XR. Dosedependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats. Neuroscience Letters 2007; 423(2): 113-117. doi: 10.1016/j.neulet.2007.06.044
26. Chao D, Balboni G, Lazarus LH, Salvadori S, Xia Y. Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cellular and Molecular Life Sciences Sci 2009; 66(6): 1105-1115. doi: 10.1007/s00018-009- 8759-5
27. Chao D, Bazzy-Asaad A, Balboni G, Xia Y. Delta-, but not mu-, opioid receptor stabilizes K[+] homeostasis by reducing Ca[2+] influx in the cortex during acute hypoxia. Journal of Cellular Physiology 2007; 212(1): 60-67. doi: 10.1002/jcp.21000
28. Peng PH, Huang HS, Lee YJ, Chen YS, Ma MC. Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. Journal of Neurochemistry 2009; 108(3): 741-754. doi: 10.1111/j.1471-4159.2008.05807.x
29. Zhu M, Liu M, Guo QL, Zhu CQ, Guo JC. Prolonged DADLE exposure epigenetically promotes Bcl-2 expression and elicits neuroprotection in primary rat cortical neurons via the PI3K/ Akt/NF-kappaB pathway. Acta Pharmacologica Sinica 2018; 39(10): 1582-1589. doi: 10.1038/aps.2018.7.
30. Erdemoglu E, Guney M, Giray SG, Take G, Mungan T. Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia. European Journal of Obstetrics & Gynecology and Reproductive Biology 2009; 145(2): 195-199. doi: 10.1016/j.ejogrb.2009.04.034
31. Blanie A, Vigue B, Benhamou D, Duranteau J, Geeraerts T. The frontal lobe and thalamus have different sensitivities to hypoxia-hypotension after traumatic brain injury: a microdialysis study in rats. Journal of Neurotrauma 2012; 29(18): 2782-2790. 10.1089/neu.2012.2381
32. Pagani M, Salmaso D, Sidiras GG, Jonsson C, Jacobsson H et al. Impact of acute hypobaric hypoxia on blood flow distribution in brain. Acta Physiologica [Oxf] 2011; 202(2): 203-209. doi: 10.1111/j.1748-1716.2011.02264.x
33. Feng Y, Chao D, He X, Yang Y, Kang X et al. A novel insight into neuroprotection against hypoxic/ischemic stress. Acta Physiologica Sinica 2009; 61(6): 585-592.
34. He X, Sandhu HK, Yang Y, Hua F, Belser N et al. Neuroprotection against hypoxia/ischemia: delta-opioid receptor-mediated cellular/molecular events. Cellular and Molecular Life Sciences 2013; 70(13): 2291-2303. doi: 10.1007/s00018-012-1167-2
35. Brambrink AM, Schneider A, Noga H, Astheimer A, Götz B et al. Tolerance-inducing dose of 3-nitropropionic acid modulates bcl-2 and bax balance in the rat brain: a potential mechanism of chemical preconditioning. Journal of Cerebral Blood Flow & Metabolism 2000; 20(10): 1425-1436. doi: 10.1097/00004647- 200010000-00004
36. Ma D, Hossain M, Pettet GK, Luo Y, Lim T et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. Journal of Cerebral Blood Flow & Metabolism 2006; 26(2): 199-208. doi: 10.1038/sj.jcbfm.9600184
37. Meller R, Minami M, Cameron JA, Impey S, Chen D et al. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. Journal of Cerebral Blood Flow & Metabolism 2005; 25(2): 234-246. doi: 10.1038/sj.jcbfm.9600024
38. Shimizu S, Nagayama T, Jin KL, Zhu L, Loeffert JE et al. bcl-2 Antisense treatment prevents induction of tolerance to focal ischemia in the rat brain. Journal of Cerebral Blood Flow & Metabolism 2001; 21(3): 233-243. doi: 10.1097/00004647- 200103000-00007
39. Wu C, Fujihara H, Yao J, Qi S, Li H et al. Different expression patterns of Bcl-2, Bcl-xl, and Bax proteins after sublethal forebrain ischemia in C57Black/Crj6 mouse striatum. Stroke 2003; 34(7): 1803-1808. doi: 10.1161/01. STR.0000077255.15597.69
40. Flusberg DA, Sorger PK. Surviving apoptosis: life-death signaling in single cells. Trends in Cell Biology 2015; 25(8): 446-458. doi: 10.1016/j.tcb.2015.03.003
41. Rybnikova E, Sitnik N, Gluschenko T, Tjulkova E, Samoilov MO. The preconditioning modified neuronal expression of apoptosis-related proteins of Bcl-2 superfamily following severe hypobaric hypoxia in rats. Brain Research 2006; 1089(1): 195-202. doi: 10.1016/j.brainres.2006.03.053
42. Fujimura M, Morita-Fujimura Y, Noshita N, Sugawara T, Kawase M et al. The cytosolic antioxidant copper/ zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. Journal of Neuroscience 2000; 20(8): 2817-2824. doi: 10.1523/JNEUROSCI.20-08-02817.2000
43. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nature Reviews Neuroscience 2006; 7(6): 437-448. doi: 10.1038/nrn1927
44. Chao D, Xia Y. Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it? Progress in Neurobiology 2010; 90(4): 439-470. doi: 10.1016/j.pneurobio.2009.12.007